ESMO 2023 Highlights: Developments in Melanoma

Join Marco Donia as he discusses the intriguing results on melanoma, presented at ESMO 2023. While no groundbreaking shifts occurred, some of the notable findings include promising responses in rare melanoma subtypes, novel combinations for uveal melanoma, and potentially life-changing treatments for brain metastasis patients, on which he elaborates in this MEDtalk.